Cargando…
Predicting the public health impact of bivalent vaccines and nirmatrelvir-ritonavir against COVID-19
BACKGROUND: Uptake of COVID-19 bivalent vaccines and oral medication nirmatrelvir-ritonavir (Paxlovid) has remained low across the United States. Assessing the public health impact of increasing uptake of these interventions in key risk groups can guide further public health resources and policy. ME...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cold Spring Harbor Laboratory
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246024/ https://www.ncbi.nlm.nih.gov/pubmed/37292707 http://dx.doi.org/10.1101/2023.05.18.23289533 |